MedPharm Holdings announced the successful formulation and development of micro-emulsified, cannabis infused, dissolvable thin strips “Melts,” created with proprietary Lipophilic Enhanced Absorption Formulation (LEAF) technology. The oral strip is unique in that it micro encapsulates cannabinoids in a water-soluble delivery system. This comes on the heels of a major announcement from publicly traded Medicine Man Technologies (MDCL) to acquire MedPharm Holdings, LLC.
“Melts” is a dissolvable oral thin strip (similar to Listerine Pocketpaks) that allows for a consistent and exact cannabis dose, which isn't available through smoking or vaping cannabis directly. When combined with micro-emulsification of cannabinoids into a water-soluble substrate, “Melts” also avoids some issues created by oral cannabis dosing, such as delayed onset, which can lead to users taking too much cannabis. “Melts” will allow consumers to more easily self-regulate their dose. “Melts” will be available as both a microdose and a higher THC dose, with varying ratios of THC, CBD and terpene profiles for consumer needs.
MedPharm will deliver a rapid-onset product, manufactured under GMP conditions. This convenient dosage form will be popular with consumers who want a discreet, but rapid, dose of cannabinoids, allowing for easier consumption throughout the day. MedPharm plans to begin production of Melts in Q3 2019, sold in both a single pack and a multi-pack.